Christopher T. Saeui

655 total citations
25 papers, 507 citations indexed

About

Christopher T. Saeui is a scholar working on Molecular Biology, Organic Chemistry and Cell Biology. According to data from OpenAlex, Christopher T. Saeui has authored 25 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Cell Biology. Recurrent topics in Christopher T. Saeui's work include Glycosylation and Glycoproteins Research (15 papers), Biochemical and Molecular Research (5 papers) and Cannabis and Cannabinoid Research (4 papers). Christopher T. Saeui is often cited by papers focused on Glycosylation and Glycoproteins Research (15 papers), Biochemical and Molecular Research (5 papers) and Cannabis and Cannabinoid Research (4 papers). Christopher T. Saeui collaborates with scholars based in United States and Egypt. Christopher T. Saeui's co-authors include Kevin J. Yarema, Christian Agatemor, Mohit P. Mathew, Rahul Bhattacharya, Sagar Shah, Patawut Bovonratwet, Elaine Tan, Jennifer H. Elisseeff, Anirudha Singh and Hui Zhang and has published in prestigious journals such as PLoS ONE, Biomaterials and Frontiers in Immunology.

In The Last Decade

Christopher T. Saeui

25 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher T. Saeui United States 14 379 116 109 76 65 25 507
Rossella Di Stasi Italy 16 377 1.0× 123 1.1× 88 0.8× 59 0.8× 89 1.4× 33 595
Hongyu Zhang China 15 465 1.2× 34 0.3× 130 1.2× 78 1.0× 64 1.0× 31 703
Jeremy Griggs United Kingdom 8 210 0.6× 97 0.8× 46 0.4× 178 2.3× 187 2.9× 8 541
Hsiang-Ling Huang Taiwan 11 287 0.8× 71 0.6× 15 0.1× 44 0.6× 88 1.4× 15 550
Venkata Paruchuri United States 4 297 0.8× 182 1.6× 71 0.7× 66 0.9× 42 0.6× 4 360
Weicai Chen China 15 495 1.3× 32 0.3× 27 0.2× 74 1.0× 91 1.4× 32 726
Reinhard Zeitler Germany 8 650 1.7× 335 2.9× 94 0.9× 88 1.2× 45 0.7× 11 720
Beáta Biri‐Kovács Hungary 13 252 0.7× 32 0.3× 30 0.3× 38 0.5× 80 1.2× 29 388
Scott L. Lauren United States 6 264 0.7× 32 0.3× 55 0.5× 67 0.9× 56 0.9× 11 402
Thomas R. Peavy United States 10 248 0.7× 64 0.6× 57 0.5× 54 0.7× 22 0.3× 14 485

Countries citing papers authored by Christopher T. Saeui

Since Specialization
Citations

This map shows the geographic impact of Christopher T. Saeui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher T. Saeui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher T. Saeui more than expected).

Fields of papers citing papers by Christopher T. Saeui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher T. Saeui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher T. Saeui. The network helps show where Christopher T. Saeui may publish in the future.

Co-authorship network of co-authors of Christopher T. Saeui

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher T. Saeui. A scholar is included among the top collaborators of Christopher T. Saeui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher T. Saeui. Christopher T. Saeui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saeui, Christopher T., Sagar Shah, Beatriz I. Fernández-Gil, et al.. (2023). Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway. ACS Chemical Biology. 18(1). 151–165. 4 indexed citations
2.
Du, Jian, Christian Agatemor, Christopher T. Saeui, et al.. (2021). Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified N-Acetylmannosamine (ManNAc) Analogs. Cells. 10(2). 377–377. 12 indexed citations
3.
Saeui, Christopher T., Alison V. Nairn, Melina Galizzi, et al.. (2020). Cell Line-, Protein-, and Sialoglycosite-Specific Control of Flux-Based Sialylation in Human Breast Cells: Implications for Cancer Progression. Frontiers in Chemistry. 8. 13–13. 8 indexed citations
4.
Saeui, Christopher T., et al.. (2020). FDA perspective on the preclinical development of cell-based immunotherapies. Cell and Gene Therapy Insights. 6(9). 1381–1390. 2 indexed citations
5.
Agatemor, Christian, et al.. (2019). Exploiting metabolic glycoengineering to advance healthcare. Nature Reviews Chemistry. 3(10). 605–620. 130 indexed citations
6.
Saeui, Christopher T., Alison V. Nairn, Melina Galizzi, et al.. (2018). Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes. PLoS ONE. 13(5). e0195812–e0195812. 15 indexed citations
7.
Shah, Sagar, et al.. (2018). Improving Immunotherapy Through Glycodesign. Frontiers in Immunology. 9. 2485–2485. 50 indexed citations
8.
Wang, Qiong, Cheng‐Yu Chung, Weiming Yang, et al.. (2018). Combining Butyrated ManNAc with Glycoengineered CHO Cells Improves EPO Glycan Quality and Production. Biotechnology Journal. 14(4). e1800186–e1800186. 22 indexed citations
9.
Kilburn, Duncan, Jueping Song, Yulan Cheng, et al.. (2017). Determination of absolute expression profiles using multiplexed miRNA analysis. PLoS ONE. 12(7). e0180988–e0180988. 13 indexed citations
10.
Badr, Haitham A., Dina M.M. AlSadek, Motawa E. El-Houseini, et al.. (2016). Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example. Biomaterials. 116. 158–173. 21 indexed citations
11.
Mathew, Mohit P., Elaine Tan, Christopher T. Saeui, et al.. (2015). Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib. Bioorganic & Medicinal Chemistry Letters. 25(6). 1223–1227. 26 indexed citations
12.
Saeui, Christopher T., et al.. (2015). Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications. Glycoconjugate Journal. 32(7). 425–441. 17 indexed citations
13.
Tian, Yuan, Caitlin H. Choi, Qing Kay Li, et al.. (2015). Identification of sialylated glycoproteins from metabolically oligosaccharide engineered pancreatic cells. Clinical Proteomics. 12(1). 11–11. 30 indexed citations
14.
Saeui, Christopher T., et al.. (2015). Biodynamic performance of hyaluronic acid versus synovial fluid of the knee in osteoarthritis. Methods. 84. 90–98. 21 indexed citations
15.
Saeui, Christopher T., et al.. (2015). Cell Surface and Membrane Engineering: Emerging Technologies and Applications. Journal of Functional Biomaterials. 6(2). 454–485. 23 indexed citations
16.
Saeui, Christopher T., Nathan P. Charlton, & William J. Brady. (2010). Biochemical issues in emergency medicine: diagnostic and therapeutic considerations of selected toxic presentations. The American Journal of Emergency Medicine. 30(1). 231–235. 6 indexed citations
17.
Worm, Karin, Christopher T. Saeui, Joel Cassel, et al.. (2009). Discovery of N-(3-(morpholinomethyl)-phenyl)-amides as potent and selective CB2 agonists. Bioorganic & Medicinal Chemistry Letters. 19(17). 5004–5008. 6 indexed citations
18.
Bourdonnec, Bertrand Le, Karin Worm, Catherine Goodman, et al.. (2009). Novel sulfamoyl benzamides as selective CB2 agonists with improved in vitro metabolic stability. Bioorganic & Medicinal Chemistry Letters. 20(1). 387–391. 9 indexed citations
19.
Chu, Guo‐Hua, Christopher T. Saeui, Karin Worm, et al.. (2009). Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 19(20). 5931–5935. 12 indexed citations
20.
Worm, Karin, Christopher T. Saeui, Joel Cassel, et al.. (2008). Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands. Bioorganic & Medicinal Chemistry Letters. 18(9). 2830–2835. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rossella Di Stasi Breakdown of academic impact, for papers by Hongyu Zhang Breakdown of academic impact, for papers by Jeremy Griggs Breakdown of academic impact, for papers by Hsiang-Ling Huang Breakdown of academic impact, for papers by Venkata Paruchuri Breakdown of academic impact, for papers by Weicai Chen Breakdown of academic impact, for papers by Reinhard Zeitler Breakdown of academic impact, for papers by Beáta Biri‐Kovács Breakdown of academic impact, for papers by Scott L. Lauren Breakdown of academic impact, for papers by Thomas R. Peavy
Rankless by CCL
2026